コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 ferences and GABA(A)R subunit specificity in alcohol intake.
2 ealth 2000), with available data on baseline alcohol intake.
3 diabetes, smoking, sedentary behaviors, and alcohol intake.
4 rior or current viral hepatitis or excessive alcohol intake.
5 own of CRMP-2 in the NAc decreases excessive alcohol intake.
6 alcohol use disorder or is a consequence of alcohol intake.
7 re to measure lifetime use or the pattern of alcohol intake.
8 ved stress, depression, dietary factors, and alcohol intake.
9 d portal hypertension in patients with heavy alcohol intake.
10 g properties, which could promote subsequent alcohol intake.
11 l relevance of kinase activity for excessive alcohol intake.
12 l appear to be a crucial factor in promoting alcohol intake.
13 restored BDNF levels and decreased excessive alcohol intake.
14 activity of this neuronal population reduces alcohol intake.
15 a causal relationship between D2R levels and alcohol intake.
16 in the transition from moderate to excessive alcohol intake.
17 ic symptoms of withdrawal and for regulating alcohol intake.
18 nd adjusted for sex, education, smoking, and alcohol intake.
19 e important mediators of this stress-induced alcohol intake.
20 d prevented withdrawal-induced escalation of alcohol intake.
21 tral role in mechanisms underlying excessive alcohol intake.
22 ns with diet have been convincing other than alcohol intake.
23 ce observed in sP rats and to their elevated alcohol intake.
24 wo inbred strains of mice known to differ in alcohol intake.
25 sensitivity in patients with sustained heavy alcohol intake.
26 ids, education, race/ethnicity, smoking, and alcohol intake.
27 ignificant for a model using the most recent alcohol intake.
28 sure and withdrawal known to drive excessive alcohol intake.
29 -to-NAcore inputs sustain aversion-resistant alcohol intake.
30 uch that 7.6% of deaths can be attributed to alcohol intake.
31 tral nucleus of the amygdala (CeA) decreased alcohol intake.
32 gs suggest that a GPR39 agonist would reduce alcohol intake.
33 cent to decipher the genetic architecture of alcohol intake.
34 y history of colorectal cancer, smoking, and alcohol intake.
35 , family history of diabetes, and energy and alcohol intakes.
36 , riboflavin, vitamin B-6, vitamin B-12, and alcohol intakes.
37 g years-of-life-lost were 0.5 years for high alcohol intake, 0.7 years for obesity, 3.9 years for dia
38 how that activation of NAc D1-MSNs increased alcohol intake 1-, 4-, and 24-h after the start of drink
39 under the curve=0.90-0.99) for current heavy alcohol intake (42 g per day in men and 28 g per day in
40 s of coffee per day, 13% and 7% for moderate alcohol intake, 8% and 11% for a high Alternate Healthy
41 r cumulative risk of AF for individuals with alcohol intake above an acceptable range and in the high
43 alcohol deprivation effect (the increase in alcohol intake after a period of abstinence) while havin
44 he apparently protective effects of moderate alcohol intake against stroke are largely non-causal.
52 MICs, higher income, being divorced/widowed, alcohol intake and abdominal obesity had higher odds of
53 We observed a J-shaped association between alcohol intake and all-cause death with a maximal risk r
55 serotonin receptor agonist) robustly reduced alcohol intake and BALs in HDID-1 mice, providing the fi
56 the established association between lifetime alcohol intake and breast cancer and provide evidence fo
58 al studies assessing the association between alcohol intake and cardiovascular events in the followin
60 PLX5622 prevented escalations in voluntary alcohol intake and decreased anxiety-like behavior assoc
62 administration, increased aversion-resistant alcohol intake and enhanced stress-induced relapse to al
63 studies of ALD have focused on pathological alcohol intake and few mechanistic studies of moderate a
65 t Scale-cognitive subscale, body mass index, alcohol intake and genetic variables are the most common
66 and Signature E4 is unique in ESCC linked to alcohol intake and genetic variants in alcohol-metaboliz
67 tudies have examined the association between alcohol intake and hip fractures, few have considered sp
68 estimate associations between previous day's alcohol intake and hormone concentrations, whereas Poiss
74 idence intervals for the association between alcohol intake and myocardial infarction, ischemic strok
75 f GalphasDREADD in DMS dMSNs or iMSNs alters alcohol intake and observed that CNO-dependent activatio
77 est that relaxin-3/RXFP3 signaling regulates alcohol intake and relapse-like behavior, adding to curr
78 ntake might modulate the association between alcohol intake and risk of hormone-dependent cancer.
79 dorsolateral striatum PDE10A in facilitating alcohol intake and support further investigation of PDE1
80 bjectives were to study the relation between alcohol intake and the risk of hormone-dependent cancers
81 rsive effects negatively modulates voluntary alcohol intake and thus may be important in vulnerabilit
82 studied genotypes did not predict high mean alcohol intake and were not positively associated with b
83 ts suggest that repeated cycles of excessive alcohol intake and withdrawal potentiate glutamatergic s
86 level of education, self-reported diabetes, alcohol-intake and smoking," was constructed for subset
87 of abstinence period, and quantification of alcohol intake), and if the patient is an active drinker
88 cise, body weight reduction, low to moderate alcohol intake, and adequate potassium intake are emphas
89 gs (DREADDs) were delivered after 4-weeks of alcohol intake, and clozapine-N-oxide (CNO) was administ
91 f Fyn to GalphasDREADD-dependent increase in alcohol intake, and found that systemic administration o
92 ly attenuated by the adjustment for smoking, alcohol intake, and intelligence measured at conscriptio
94 the treatment of hypertension, reduction in alcohol intake, and occlusion of the left atrial appenda
96 such as hedonic responses to palatable food, alcohol intake, and reinstatement of cocaine seeking.
99 position, physical activity, diet, smoking, alcohol intake, and use of oral contraceptives (per 1-un
100 e mineral density, urticaria pigmentosa, and alcohol intake are easy to collect in clinical practice.
102 ensity, absence of urticaria pigmentosa, and alcohol intake at the time of ISM diagnosis were indepen
103 the highly conserved human GAL5.1 enhancer, alcohol intake (AUDIT questionnaire scores) and anxiety
104 of association between maternal or paternal alcohol intake before or during pregnancy and offspring
107 rtial agonist of alpha4beta2 nAChRs, reduces alcohol intake, but its use can be limited by side effec
108 this study investigated how NAc MSNs mediate alcohol intake by using Drd1a-iCre and Drd2-iCre transge
109 related to mortality in this cohort-smoking, alcohol intake, caffeine consumption, exercise, body mas
111 sted HRs over increasing cumulative averaged alcohol intake categories were 1.00 (reference) for nond
112 d on deterrent health factors, like smoking, alcohol intake, cheese consumption and average systolic
115 ex, physical activity level, smoking status, alcohol intake, depression, self-reported general health
117 nicable diseases (NCDs) only listed smoking, alcohol intake, diet and physical activity (PA) as key m
118 nal assessments of body mass index, smoking, alcohol intake, diet quality, physical activity, and ant
119 utions of health-related behaviors (smoking, alcohol intake, diet, physical activity, and sedentary t
121 ear, based on self-reported information: any alcohol intake (drinker/non-drinker status) and the regu
122 ate this, we used a mouse model of voluntary alcohol intake (Drinking-in-the-Dark-Multiple Scheduled
123 between education, beverage and non-beverage alcohol intake, drinking patterns, and acute alcohol-rel
126 expectation, D2R upregulation did not reduce alcohol intake during continuous or intermittent access
128 ificant reductions of relapse-like excessive alcohol intake during the post-abstinence drinking days,
130 ping behaviors in real life, including binge alcohol intake, emotional eating, and frequency of argum
131 en, cirrhosis incidence increases with total alcohol intake, even at moderate levels of consumption.
132 cancer risk was observed for higher lifetime alcohol intake (for >/=230 drinks/year vs. <60 drinks/ye
133 cross all substance use traits, particularly alcohol intake, for which 38% of the phenotypic variance
135 increased EA were associated with increased alcohol intake frequency (B(IVW) = 0.331, 95% CI, 0.267-
136 patients in the control group reduced their alcohol intake from 16.4+/-6.9 to 13.2+/-6.5 drinks per
137 tients in the abstinence group reduced their alcohol intake from 16.8+/-7.7 to 2.1+/-3.7 standard dri
138 ceived a motivational intervention to reduce alcohol intake from either the hygienist or dentist.
139 iology) or with genotype-predicted mean male alcohol intake (genetic epidemiology-ie, Mendelian rando
140 rity, socio-occupational status, smoking and alcohol intake, gestational week of blood sampling, and
143 ional epidemiology showed that self-reported alcohol intake had U-shaped associations with the incide
145 tribution of acute withdrawal relief to high alcohol intake has been difficult to model in animals.
148 le factors (e.g. diet, physical activity and alcohol intake) have been suggested as risk factors for
149 , lifestyle (smoking, physical activity, and alcohol intake), health history and medication use, and
150 s later (year 20): not overweight/obese, low alcohol intake, healthy diet, physically active, nonsmok
151 ion scale (SATED): <8); smoking status; and, alcohol intake (high-risk drinker based on standard drin
152 e, field center, physical activity, smoking, alcohol intake, high-density lipoprotein-cholesterol, to
155 [CI], 1.16; 3.25; P = 0.012); past excessive alcohol intake (HR, 1.55; 95% CI, 1.02; 2.36; P = 0.041)
156 e combination of a high index score and high alcohol intake (HRs: 2.29 for all-cause and 1.78 for CVD
157 p with low mental health index score and low alcohol intake, HRs (95% CIs) for all-cause mortality we
159 entration, naltrexone selectively suppressed alcohol intake in 118GG animals to a level virtually ide
160 nine dinucleotide (CpG) sites in relation to alcohol intake in 13 population-based cohorts (ntotal=13
162 udy provides evidence in support of limiting alcohol intake in adherence to the USDGA recommendations
163 eceptor (GR) antagonist mifepristone reduces alcohol intake in alcohol-dependent rats but not in nond
164 e in current drinkers and genotype-predicted alcohol intake in all men had similarly strong positive
165 GSK1521498) reduced both alcohol seeking and alcohol intake in compulsive and non-compulsive rats, in
166 nnel inhibitor apamin into the NAc increased alcohol intake in control C57BL/6J mice, while spontaneo
167 e conditioning response rate decreased under alcohol intake in controls, it increased in patients (an
169 naptome found cross-species genetic links to alcohol intake in discrete proteins (e.g., C2CD2L, DIRAS
170 on alcohol intake while inhibition increased alcohol intake in Drd2-iCre rats for 1-h in males and 4-
173 the BNST dose-dependently blocked excessive alcohol intake in ethanol-dependent rats without affecti
175 g concept was demonstrated for monitoring of alcohol intake in human subjects over multiple drinking
177 contraceptive pills in females, smoking and alcohol intake in males did not differ significantly amo
179 diovascular risk and genotype-predicted mean alcohol intake in men, contrasting the findings in men w
180 ol drinking, but CNO injection did not alter alcohol intake in mice that were treated with control vi
186 inputs to DA cells and CB1 receptors affect alcohol intake in rodents, we hypothesized that the endo
189 uced both cue-controlled alcohol seeking and alcohol intake in the instrumental context as well as al
190 cted drinking behaviors, including amount of alcohol intakes (in total and various types), drinking f
196 f a highly prevalent form of drinking, binge alcohol intake, influences enzyme priming or the functio
197 nificantly related to higher total amount of alcohol intake (inverse-variance weighted method (IVW):
200 Compared with no alcohol consumption, heavy alcohol intake is associated with a higher rate of heart
202 derly community-based population, increasing alcohol intake is associated with subtle alterations in
206 , a behavior characterized by rapid repeated alcohol intake, is most prevalent in young adults and is
207 triatal, and limbic structures that regulate alcohol intake, it has been difficult to disentangle how
210 Kcnn3 in the NAc negatively correlated with alcohol intake levels in BXD strains, and alcohol depend
211 om Checklist, and according to self-reported alcohol intake (low, <2; light, 2-11.99; moderate, 12-23
214 ol drinking.SIGNIFICANCE STATEMENT Long-term alcohol intake may lead to neuroadaptations in the mesos
215 Thinner inner retina was associated with alcohol intake (most significant for GCIPL: -0.46 mum fo
216 ied into 4 categories based on self-reported alcohol intake: nondrinkers, drinkers of </=7, >/=7 to 1
217 the transition from moderate to uncontrolled alcohol intake occurs, in part, upon a breakdown of this
218 mass index (weight (kg)/height (m)(2)), and alcohol intake (odds ratio = 0.82, 95% confidence interv
219 of 21% (95% confidence interval, 5%-34%) at alcohol intake of 0-9 g/day compared to lifetime abstain
223 e regarding the largely adverse influence of alcohol intake on cardiovascular health in an Asian popu
224 ortality and morbidity, the effect of recent alcohol intake on female reproductive function has not b
225 were to investigate the effects of moderate alcohol intake on thermogenic brown/beige adipocyte form
226 d not include women, had data on smoking and alcohol intake only in a subsample, and lacked repeated
227 mic risk stratification, and to test whether alcohol intake or body mass index interacts with polygen
228 and Laird random-effects models to model any alcohol intake or dose-response relationships of alcohol
232 e of lower mortality risk with low levels of alcohol intake over time but higher mortality risk for t
233 association remained consistent when we used alcohol intakes over different latency periods (0-4, 4-8
236 ociations of body mass index (BMI), smoking, alcohol intake, parity and age at menarche with changes
237 otential confounders such as sleep duration, alcohol intake, physical activity, and current smoking.
238 ter, year of screening exam, smoking status, alcohol intake, physical activity, education level, tota
239 cy body mass index (BMI), parity, education, alcohol intake, physical activity, smoking, and breastfe
240 ational position, 25 x 25 risk factors (high alcohol intake, physical inactivity, current smoking, hy
241 social class, education, physical activity, alcohol intake, plasma vitamin C, history of cardiovascu
244 Here, we show that a history of excessive alcohol intake produces neuroadaptations in the DLS that
246 In a subpopulation with longitudinal data, alcohol intake remained stable over time in >80% of subj
248 core combined with light, moderate, and high alcohol intake, respectively, and 1.11 (0.98, 1.25; p =
252 blink reflex recovery cycle before and after alcohol intake resulting in a breath alcohol concentrati
253 bacco smoking (RR, 2.47; 95% CI, 2.12-2.87), alcohol intake (RR, 1.33; 95% CI, 1.17-1.52), body mass
254 odel, adjusted for age; sex; smoking status; alcohol intake; SBP; DBP; cholesterol:high-density lipop
255 extended amygdala are recruited by excessive alcohol intake, sensitized by repeated withdrawal, and c
256 Survival models were adjusted for age, sex, alcohol intake, smoking history, and educational attainm
257 onal hazards regression, after adjusting for alcohol intake, smoking, body mass index, diabetes, and
258 vation, urban or rural residence, education, alcohol intake, smoking, leisure physical activity, recr
259 eg, hypertension, hyperlipidaemia, excessive alcohol intake, smoking, obesity, and sedentary lifestyl
260 r, LM11A-31, significantly reduces excessive alcohol intake suggesting that the drug may be developed
261 in patients who improved significantly with alcohol intake suggests a crucial role of cerebellar net
262 ved regulatory mechanism linking anxiety and alcohol intake that might contribute to increased suscep
263 and D-cycloserine on this aversion-resistant alcohol intake (that persists despite adulteration with
265 on adjusted for age, education, smoking, and alcohol intake to estimate the associations between lead
267 ight, body mass index (BMI), smoking status, alcohol intake, Townsend deprivation index, education le
268 g, body-mass index (BMI), physical activity, alcohol intake, type 2 diabetes and parity, use of hormo
270 trast, although genotype-predicted mean male alcohol intake varied widely (from 4 to 256 g per week-i
271 n causes of chronic liver disease are excess alcohol intake, viral hepatitis and non-alcoholic fatty
278 ex-specific median of dietary fiber intake), alcohol intake was directly associated with hormone-depe
280 infarction, however, genotype-predicted mean alcohol intake was not significantly associated with ris
283 characteristics of patients were comparable; alcohol intake was the most common etiology of cirrhosis
285 k factors, overall HRs per 10-g increment in alcohol intake were 0.94 (95% CI: 0.89, 0.98) for CAD an
286 d to saturated fat, vegetables, and moderate alcohol intake were components of the diet quality score
287 HRs and 95% CIs for BCC in association with alcohol intake were computed with the use of Cox proport
290 with more mental health problems and a high alcohol intake were increased when the risk factors occu
291 , smoking, physical activity, and energy and alcohol intakes were pooled by using a random-effects mo
292 229984), known to be associated with greater alcohol intake, were found to consume less alcohol if th
293 QR 2000-03), the participants reported their alcohol intake, whether consumption was usually with mea
294 A as a neuroadaptation maintaining excessive alcohol intake, which may contribute to the propensity t
296 Activation of NAc D2-MSNs had no impact on alcohol intake while inhibition increased alcohol intake
298 s in the association of obesity, smoking, or alcohol intake with prostate cancer risk and mortality b
299 ith 0.69% (95% CI, 0.58-0.80) for those with alcohol intake within an acceptable range and in the low
300 ensin receptor antagonists), smoking status, alcohol intake, years of education, temperature, and sea